Inhibition of Experimental Asthma in Man by a New Drug (AH 7725) Active when Given by Mouth
- 13 April 1974
- Vol. 2 (5910) , 93-95
- https://doi.org/10.1136/bmj.2.5910.93
Abstract
A new drug, AH 7725, with properties similar to those of disodium cromoglycate (Intal) has the additional feature of being effective when taken by mouth. Six patients with allergic asthma were studied by bronchial challenge tests with antigen. In every one the drug was found to inhibit (either partially or completely) the immediate-type asthmatic response. Late responses were not influenced. The results were significant at the 0·5% level. These findings suggest that AH 7725 given by mouth may be able to inhibit naturally occurring asthmatic attacks in allergic patients. In this case its particular advantage as a prophylactic drug would lie in the treatment of very young asthmatic children and other patients who cannot take drugs by inhalation.Keywords
This publication has 7 references indexed in Scilit:
- Changes in challenge tests following hyposensitization with mite extractClinical and Experimental Allergy, 1973
- Inhibition of Allergic Reactions by Cromoglycate and by a New Series of Compounds (AH 6556, AH 7079 and AH 7725)International Archives of Allergy and Immunology, 1973
- Inhibition of Allergic Reactions by Cromoglycate and by AH 7079 in Patients with Allergic Airway DiseaseInternational Archives of Allergy and Immunology, 1973
- House-dust Mite Asthma. Results of Challenge Tests on Five Criteria with Dermatophagoides pteronyssinusBMJ, 1970
- INHIBITORY EFFECTS OF DISODIUM CROMOGLYCATE ON ALLERGEN-INHALATION TESTSThe Lancet, 1968
- Disodium Cromoglycate (FPL 670) (‘Intal’*): a Specific Inhibitor of Reaginic Antibody–Antigen MechanismsNature, 1967
- INDUCED ASTHMA IN MANThe Lancet, 1951